CN Patent

CN104173342A — 一种右旋兰索拉唑组合物

Assigned to Fuzhou Minhai Pharmaceutical Co Ltd · Expires 2014-12-03 · 11y expired

What this patent protects

本发明一种右旋兰索拉唑组合物，所述组合物包括以下重量比的组分：右旋兰索拉唑 0.5-2；抗酸剂0.6；抗氧化剂0.5；崩解剂0.3。本发明一种右旋兰索拉唑组合物，通过在传统的右旋兰索拉唑中加入抗酸剂、抗氧化剂等，可明显提高右旋兰索拉唑的稳定性，使得右旋兰索拉唑的活性保持更持久，减少了右旋兰索拉唑在放置过程中，反应副产物的产生，有利于提高右旋兰索拉唑制剂的稳定性。

USPTO Abstract

本发明一种右旋兰索拉唑组合物，所述组合物包括以下重量比的组分：右旋兰索拉唑 0.5-2；抗酸剂0.6；抗氧化剂0.5；崩解剂0.3。本发明一种右旋兰索拉唑组合物，通过在传统的右旋兰索拉唑中加入抗酸剂、抗氧化剂等，可明显提高右旋兰索拉唑的稳定性，使得右旋兰索拉唑的活性保持更持久，减少了右旋兰索拉唑在放置过程中，反应副产物的产生，有利于提高右旋兰索拉唑制剂的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN104173342A
Jurisdiction
CN
Classification
—
Expires
2014-12-03
Drug substance claim
No
Drug product claim
No
Assignee
Fuzhou Minhai Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.